SCI时时刷

search
+
Nebivolol, an antihypertensive agent, has new application in inhibiting melanoma
Nebivolol, an antihypertensive agent, has new application in inhibiting melanoma
Repurposing existing drugs for cancer therapy has become an important strategy because of its advant
A comprehensive clinical evaluation of HER2-TKIs in patients with previously treated HER2-positive metastatic breast cancer
A comprehensive clinical evaluation of HER2-TKIs in patients with previously treated HER2-positive metastatic breast cancer
Human epidermal growth factor receptor 2-tyrosine kinase inhibitors (HER2-TKIs) have been extensivel
Twelve-month progression-free survival with sotorasib and panitumumab in KRAS G12C mutant metastatic colorectal cancer
Twelve-month progression-free survival with sotorasib and panitumumab in KRAS G12C mutant metastatic colorectal cancer
Colorectal cancer (CRC) ranks third in global cancer prevalence, with 40% presenting as metastatic c
Concurrent NRAS-BRAF variants in metastatic colorectal cancer: a Tunisian case report
Concurrent NRAS-BRAF variants in metastatic colorectal cancer: a Tunisian case report
Target therapy for metastatic colorectal cancer needs the determination of KRAS, NRAS, and BRAF muta
A phase 1 study of regorafenib and sildenafil in adults with advanced solid tumors
A phase 1 study of regorafenib and sildenafil in adults with advanced solid tumors
The purpose of this study is to establish the recommended phase 2 dose for regorafenib in combinatio
HMOX1 regulates ferroptosis via mic14 and its impact on chemotherapy resistance in small-cell lung cancer
HMOX1 regulates ferroptosis via mic14 and its impact on chemotherapy resistance in small-cell lung cancer
This study aimed to investigate the role and molecular mechanism of heme oxygenase-1 (HMOX1) in chem
Anoikis-related lncRNA signature predicts prognosis and is associated with immune infiltration in hepatocellular carcinoma
Anoikis-related lncRNA signature predicts prognosis and is associated with immune infiltration in hepatocellular carcinoma
Anoikis is a programmed cell death process triggered when cells are dislodged from the extracellular
Response to Yilmaz et al.
Response to Yilmaz et al.
aMedical Oncology Department, Instituto de Investigación Sanitaria San Carlos (IdISSC) bDepartment of Otolary...
Anlotinib plus Sintilimab achieved in an antitumor effect of complete remission in a patient with advanced hepatocellular carcinoma: a case report
Anlotinib plus Sintilimab achieved in an antitumor effect of complete remission in a patient with advanced hepatocellular carcinoma: a case report
Systemic therapies-based combination treatments have been developed rapidly in patients with advance
Urinary exosomal mRNA as a biomarker for the diagnosis of bladder cancer
Urinary exosomal mRNA as a biomarker for the diagnosis of bladder cancer
Objective To study the diagnostic value of mRNA expression in urinary exocrine body in bladder ca
Hydroxychavicol sensitizes imatinib-resistant chronic myelogenous leukemia cells to TRAIL-induced apoptosis by ROS-mediated IAP downregulation: Erratum
Hydroxychavicol sensitizes imatinib-resistant chronic myelogenous leukemia cells to TRAIL-induced apoptosis by ROS-mediated IAP downregulation: Erratum
The histogram at 120 min in Fig. 4b of this article [1] was incorrect. The correct image is shown below. 1. Pau...
Design of potential anti-cancer agents as COX-2 inhibitors, using 3D-QSAR modeling, molecular docking, oral bioavailability proprieties, and molecular dynamics simulation: Erratum
Design of potential anti-cancer agents as COX-2 inhibitors, using 3D-QSAR modeling, molecular docking, oral bioavailability proprieties, and molecular dynamics simulation: Erratum
The two graphs in Figure 5 of this paper [1] are incorrect and are mistakenly those that appeared in Figure 6. The correct...
miR-26b-5p suppresses chemoresistance in breast cancer by targeting serglycin: Erratum
miR-26b-5p suppresses chemoresistance in breast cancer by targeting serglycin: Erratum
miR-26b-5p suppresses chemoresistance in breast cancer by ta... : Anti-Cancer Drugs ...
Clinical and radiological evaluation of a phyllodes tumor of the breast: a case report
Clinical and radiological evaluation of a phyllodes tumor of the breast: a case report
Phyllodes tumors (PTs) are rare breast tumors characterized by varying biological behavior and heter
Jackfruit waste: an invented anticancer therapy using Jacalin lectin from jackfruit seed
Jackfruit waste: an invented anticancer therapy using Jacalin lectin from jackfruit seed
Every food source contains both edible and inedible waste components. Millions of tonnes of trash fr
A late relapse thymoma and pure red cell aplasia case with an over 5 years of clinical response under everolimus
A late relapse thymoma and pure red cell aplasia case with an over 5 years of clinical response under everolimus
Although several agents showed some clinical activity in patients with recurrent thymoma, there is n
In regard to Cabezas-Camarero et al.
In regard to Cabezas-Camarero et al.
aDepartment of Radiation Oncology, Ankara Etlik State Hospital bDepartment of Radiation Oncology, Hacettepe U...
Cellular responses after (neratinib plus pemetrexed) exposure in NSCLC cells
Cellular responses after (neratinib plus pemetrexed) exposure in NSCLC cells
We previously demonstrated that neratinib interacted with pemetrexed to kill non-small cell lung can
STK25: a viable therapeutic target for cancer treatments?
STK25: a viable therapeutic target for cancer treatments?
Serine/threonine protein kinase 25 (STK25) is a critical regulator of ectopic lipid storage, glucose
APLNR promotes the progression of osteosarcoma by stimulating cell proliferation and invasion: Retraction
APLNR promotes the progression of osteosarcoma by stimulating cell proliferation and invasion: Retraction
The corresponding author has requested retraction of this article [1] as they cannot verify the uniqueness of the images u...
RIDR-PI-103, ROS-activated prodrug PI3K inhibitor inhibits cell growth and impairs the PI3K/Akt pathway in BRAF and MEK inhibitor-resistant BRAF-mutant melanoma cells
RIDR-PI-103, ROS-activated prodrug PI3K inhibitor inhibits cell growth and impairs the PI3K/Akt pathway in BRAF and MEK inhibitor-resistant BRAF-mutant melanoma cells
Reactive oxygen species (ROS) levels are elevated after acquisition of resistance to v-raf murine sa
A novel combination of isovanillin, curcumin, and harmine (GZ17-6.02) enhances cell death and alters signaling in actinic keratoses cells when compared to individual components and two-component combinations
A novel combination of isovanillin, curcumin, and harmine (GZ17-6.02) enhances cell death and alters signaling in actinic keratoses cells when compared to individual components and two-component combinations
Actinic keratosis is a pre-malignant skin disease caused by excessive exposure to ultraviolet light.
Uveitis, a rare but important complication of adjuvant zoledronic acid for early-stage breast cancer
Uveitis, a rare but important complication of adjuvant zoledronic acid for early-stage breast cancer
Bisphosphonates such as zoledronic acid are an important part of adjuvant therapy to reduce the risk
Synthesis and evaluation of novel thiazole moiety-containing compounds as antibreast cancer agents
Progesterone receptor (PR) agonists represent pivotal agents in trapping breast cancer cells through
Circular RNA circ-AGFG1 contributes to esophageal squamous cell carcinoma progression and glutamine catabolism by targeting microRNA-497-5p/solute carrier family 1 member 5 axis
Circular RNA circ-AGFG1 contributes to esophageal squamous cell carcinoma progression and glutamine catabolism by targeting microRNA-497-5p/solute carrier family 1 member 5 axis
Circular RNAs (circRNAs) have been shown to play important regulatory roles in human malignancies. H
Palbociclib enhances the effect of doxorubicin-induced apoptosis in activated B-cell–like diffuse large B-cell lymphoma cells
Palbociclib enhances the effect of doxorubicin-induced apoptosis in activated B-cell–like diffuse large B-cell lymphoma cells
Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma around the world. Whil
Identification and validation of RB1 as an immune-related prognostic signature based on tumor mutation burdens in bladder cancer
Identification and validation of RB1 as an immune-related prognostic signature based on tumor mutation burdens in bladder cancer
Bladder cancer (BCa) is one of the most common malignant tumors in the urinary system. Developing ef
Reuse of osimertinib after small cell lung cancer transformation in lung adenocarcinoma with de-novo epidermal growth factor receptor T790M mutation: case report
Reuse of osimertinib after small cell lung cancer transformation in lung adenocarcinoma with de-novo epidermal growth factor receptor T790M mutation: case report
Osimertinib is a third-generation tyrosine kinase inhibitor for non-small cell lung cancer (NSCLC) p
Treatment of metastatic alveolar soft part sarcoma with axitinib and pembrolizumab in an 80-year-old patient with a history of autoimmune disorders
Treatment of metastatic alveolar soft part sarcoma with axitinib and pembrolizumab in an 80-year-old patient with a history of autoimmune disorders
Alveolar soft part sarcoma (ASPS) is a rare malignancy with low sensitivity to chemotherapy. While l
CDKN2B-AS1 is overexpressed in polycystic ovary syndrome and sponges miR-181a to promote granulosa cell proliferation
CDKN2B-AS1 is overexpressed in polycystic ovary syndrome and sponges miR-181a to promote granulosa cell proliferation
MiR-181a suppresses the proliferation of mouse granulosa cells, which participate in polycystic ovar
阅读更多
format_indent_increase